Vapotherm resulted in rapid improvement that is believed to have averted the use of mechanical ventilation and ICU admission.
Hi-VNI Technology helped provide adequate ventilatory support for an AECOPD patient.
Vapotherm provided a decrease in work of breathing over conventional oxygen therapy.
A patient who demonstrated increased anxiety with NIPPV finds success with Vapotherm.
Use of HVNI therapy as an alternative support in pneumothorax reversal.
Heliox used in conjunction with Hi-VNI® Technology has been shown to improve ventilation and oxygenation and played an integral role in in the successful extubation.
HVNI rescued a patient in acute respiratory failure receiving HFNO therapy post-extubation.
HVNI used effectively in the management of severe bronchiolitis in a small child.
Vapotherm is a fast and safe approach for patient populations from premature neonates to hypercapnic COPD patients. Learn about Vapotherm’s technology »